Papers
3
Total Citations
41
H-Index
3
About
Ramez N. Eskander is a leading gynecologic oncologist and clinical researcher whose work centers on improving surgical outcomes and quality of life for women with gynecologic cancers. His most significant contribution is the design and execution of the landmark ROCC/GOG-3043 trial, a randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer. This work directly addresses the critical safety questions raised by the 2018 LACC trial regarding minimally invasive surgery, with his 2022 and 2025 publications (garnering 24 and 8 citations, respectively) providing pivotal evidence on perioperative outcomes and oncologic safety. Beyond surgical innovation, Eskander has explored the intersection of technology and patient well-being, as demonstrated by his pilot study on the PARO therapeutic robot, which showed decreased pain, fatigue, and anxiety in patients with recurrent ovarian carcinoma (9 citations). His research portfolio—spanning clinical trial design, surgical technique, and supportive care—has positioned him as a key voice in the ongoing debate over the role of robotics in gynecologic oncology. Eskander’s work not only advances evidence-based surgical practice but also champions the integration of innovative tools to enhance the patient experience.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3